| 1 |
Huijberts I，Pinckaers F，Olthuis S，et al. Collateral-based selection for endovascular treatment of acute ischaemic stroke in the late window（MR CLEAN-LATE）：2-year follow-up of a phase 3，multicentre，open-label，randomised controlled trial in the Netherlands ［J］. Lancet Neurol，2024，23（9）：893-900.
|
| 2 |
Thomalla G，Fiehler J，Subtil F，et al. Endovascular thrombectomy for acute ischaemic stroke with established large infarct （TENSION）：12-month outcomes of a multicentre，open-label，randomised trial ［J］.Lancet Neurol，2024，23（9）：883-892.
|
| 3 |
Sun Ⅹ，Deng Y，Zhang Y，et al. Balloon angioplasty vs medical management for intracranial artery stenosis：the BASIS randomized clinical trial ［J］. JAMA，2024，332（13）：1059-1069.
|
| 4 |
Liu J，Zhou Y，Zhang L，et al. Balloon guide catheters for endovascular thrombectomy in patients with acute ischaemic stroke due to largevessel occlusion in China （PROTECT-MT）：a multicentre，openlabel，blinded-endpoint，randomised controlled trial ［J］. Lancet，2024，404（10468）：2165-2174.
|
| 5 |
Gao F，Tong Ⅹ，Jia B，et al. Bailout intracranial angioplasty or stenting following thrombectomy for acute large vessel occlusion in China（ANGEL-REBOOT）：a multicentre，open-label，blinded-endpoint，randomised controlled trial ［J］. Lancet Neurol，2024，23（8）：797-806.
|
| 6 |
MARVEL Trial Authors for the MARVEL Investigators，Yang Q，Guo C，et al. Methylprednisolone as adjunct to endovascular thrombectomy for large-vessel occlusion stroke：the MARVEL randomized clinical trial ［J］. JAMA，2024，331（10）：840-849.
|
| 7 |
Nogueira RG，Jovin TG，Liu Ⅹ，et al. Endovascular therapy for acute vertebrobasilar occlusion （VERITAS）：a systematic review and individual patient data meta-analysis ［J］. Lancet，2025，405（10472）：61-69.
|
| 8 |
Ⅹiong Y，Campbell B，Schwamm LH，et al. Tenecteplase for ischemic stroke at 4.5 to 24 hours without thrombectomy ［J］. N Engl J Med，2024，391（3）：203-212.
|
| 9 |
Meng Ⅹ，Li S，Dai H，et al. Tenecteplase vs Alteplase for patients with acute ischemic stroke：the ORIGINAL randomized clinical trial ［J］.JAMA，2024，332（17）：1437-1445.
|
| 10 |
Li S，Gu HQ，Li H，et al. Reteplase versus Alteplase for acute ischemic stroke ［J］. N Engl J Med，2024，390（24）：2264-2273.
|
| 11 |
Albers GW，Jumaa M，Purdon B，et al. Tenecteplase for stroke at 4.5 to 24 hours with perfusion-imaging selection ［J］. N Engl J Med，2024，390（8）：701-711.
|
| 12 |
Coutts SB，Ankolekar S，Appireddy R，et al. Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion（TEMPO-2）：a randomised，open label，phase 3 superiority trial ［J］.Lancet，2024，403（10444）：2597-2605.
|
| 13 |
Adeoye O，Broderick J，Derdeyn CP，et al. Adjunctive intravenous Argatroban or Eptifibatide for ischemic stroke ［J］. N Engl J Med，2024，391（9）：810-820.
|
| 14 |
Zhao W，Li S，Li C，et al. Effects of Tirofiban on neurological deterioration in patients with acute ischemic stroke：a randomized clinical trial ［J］. JAMA Neurol，2024，81（6）：594-602.
|
| 15 |
Goeldlin MB，Hakim A，Branca M，et al. Early vs late anticoagulation in minor，moderate，and major ischemic stroke with atrial fibrillation：post hoc analysis of the ELAN randomized clinical trial ［J］. JAMA Neurol，2024，81（7）：693-702.
|
| 16 |
Kelly P，Lemmens R，Weimar C，et al. Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke（CONVINCE）：a randomised controlled trial ［J］. Lancet，2024，404（10448）：125-133.
|
| 17 |
Li J，Meng Ⅹ，Shi FD，et al. Colchicine in patients with acute ischaemic stroke or transient ischaemic attack （CHANCE-3）：multicentre，double blind，randomised，placebo controlled trial ［J］.BMJ，2024，385：e079061.
|
| 18 |
Pradilla G，Ratcliff JJ，Hall AJ，et al. Trial of early minimally invasive removal of intracerebral hemorrhage ［J］. N Engl J Med，2024，390（14）：1277-1289.
|
| 19 |
Beck J，Fung C，Strbian D，et al. Decompressive craniectomy plus best medical treatment versus best medical treatment alone for spontaneous severe deep supratentorial intracerebral haemorrhage：a randomised controlled clinical trial ［J］. Lancet，2024，403（10442）：2395-2404.
|
| 20 |
Liu Q，Mo S，Wu J，et al. Safety and efficacy of early versus delayed acetylsalicylic acid after surgery for spontaneous intracerebral haemorrhage in China （E-start）：a prospective，multicentre，open-label，blinded-endpoint，randomised trial ［J］. Lancet Neurol，2024，23（12）：1195-1204.
|
| 21 |
Connolly SJ，Sharma M，Cohen AT，et al. Andexanet for factor Ⅹa inhibitor-associated acute intracerebral hemorrhage ［J］. N Engl J Med，2024，390（19）：1745-1755.
|
| 22 |
Guo J，Chen Ⅹ，Wu M，et al. Traditional Chinese medicine FYTF-919 （Zhongfeng Ⅹingnao oral prescription） for the treatment of acute intracerebral haemorrhage：a multicentre，randomised，placebocontrolled，double-blind，clinical trial ［J］. Lancet，2024，404（10468）：2187-2196.
|
| 23 |
Wessels L，Wolf S，Adage T，et al. Localized Nicardipine release implants for prevention of vasospasm after aneurysmal subarachnoid hemorrhage：a randomized clinical trial ［J］. JAMA Neurol，2024，81（10）：1060-1065.
|
| 24 |
Ma W，Chen C，Gong Y，et al. Causal effect estimation on imaging and clinical data for treatment decision support of aneurysmal subarachnoid hemorrhage ［J］. IEEE Trans Med Imaging，2024，43（8）：2778-2789.
|
| 25 |
Truckenmueller P，Wolf S，Wasilewski D，et al. Association of fluid balance and hemoglobin decline with neurological outcome after aneurysmal subarachnoid hemorrhage ［J］. Crit Care Med，2024，52（9）：1391-1401.
|
| 26 |
English SW，Delaney A，Fergusson DA，et al. Liberal or restrictive transfusion strategy in aneurysmal subarachnoid hemorrhage ［J］. N Engl J Med，2024. Online ahead of print.
|
| 27 |
Turgeon AF，Fergusson DA，Clayton L，et al. Liberal or restrictive transfusion strategy in patients with traumatic brain injury ［J］. N Engl J Med，2024，391（8）：722-735.
|
| 28 |
Yen HC，Chuang HJ，Hsiao WL，et al. Assessing the impact of early progressive mobilization on moderate-to-severe traumatic brain injury：a randomized controlled trial ［J］. Crit Care，2024，28（1）：172.
|
| 29 |
Ko YC，Lin HY，Huang EP，et al. Intraosseous versus intravenous vascular access in upper extremity among adults with out-of-hospital cardiac arrest：cluster randomised clinical trial （VICTOR trial） ［J］.BMJ，2024，386：e079878.
|
| 30 |
Nutma S，Beishuizen A，van den Bergh WM，et al. Ghrelin for neuroprotection in post-cardiac arrest coma：a randomized clinical trial［J］. JAMA Neurol，2024，81（6）：603-610.
|
| 31 |
Li G，Lin Y，Yang J，et al. Intensive ambulance-delivered bloodpressure reduction in hyperacute stroke ［J］. N Engl J Med，2024，390（20）：1862-1872.
|
| 32 |
Greer DM，Helbok R，Badjatia N，et al. Fever prevention in patients with acute vascular brain injury：the INTREPID randomized clinical trial ［J］. JAMA，2024，332（18）：1525-1534.
|
| 33 |
Lavinio A，Coles JP，Robba C，et al. Targeted temperature control following traumatic brain injury：ESICM/NACCS best practice consensus recommendations ［J］. Crit Care，2024，28（1）：170.
|
| 34 |
中国医师协会神经外科医师分会神经电生理监测学组，中国研究型医院学会临床神经电生理专委会，中国人体健康科技促进会重症脑损伤专业委员会. 神经重症患者的神经电生理监测与评估专家共识 （2024版） ［J］. 中华医学杂志，2024，104（23）：2113-2122.
|
| 35 |
American College of Surgeons. Best practices guidelines in the management of traumatic brain injury ［EB/OL］. （2024-10-29）［2025-01-13］. https：//www.facs.org/media/vgfgjpfk/best-practicesguidelines-traumatic-brain-injury.pdf.
|
| 36 |
中国卒中学会，《中国卒中学会急性缺血性卒中再灌注治疗指南2024》编写组. 中国卒中学会急性缺血性卒中再灌注治疗指南2024 ［J］. 中国卒中杂志，2024，19（12）：1459-1477.
|
| 37 |
中国残疾人康复协会神经康复专业委员会，中国康复研究中心.神经重症气管切开患者气道功能康复与管理专家共识 （2024） ［J］.中国康复理论与实践，2024，30（8）：869-881.
|
| 38 |
陈雨晴，王淑雅，张琳琳，等. 2022～2023年神经重症进展与展望［J］. 中国急救医学，2024，44（1）：30-37.
|